Raymond James Financial
DRTS icon

Raymond James Financial’s Alpha Tau Medical DRTS Stock Holding History

Raymond James Financial’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,240
Closed -$3.87K – 5444
2025
Q2 		$3.87K Buy
+1,240
New +$3.49K ﹤0.01% 6245

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Raymond James Financial's DRTS Position: Q3 2025 in Review

Raymond James Financial sold out of Alpha Tau Medical (DRTS) in Q3 2025, closing a stake of 1,240 shares — an estimated $3.87K sold.

Raymond James Financial first reported a position in DRTS in Q2 2025 and held it in 1 quarter. The position peaked at $3.87K in Q2 2025. 31 funds tracked by Wall St. Rank hold DRTS as of Q3 2025.

  • Raymond James Financial reported no remaining Alpha Tau Medical position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 1,240 Alpha Tau Medical shares in Q3 2025, an estimated $3.87K.
  • Raymond James Financial first reported a position in Alpha Tau Medical in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Alpha Tau Medical position peaked at $3.87K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.